Most Clicked StoriesMore >


Study: New kappa opioid agonist may have fewer side effects

American Pain Society SmartBrief | May 20, 2015

A kappa opioid agonist under development by CARA Therapeutics shows promise for reducing pain with fewer side effects associated with the drug class, researchers reported at the American Pain Society's annual meeting. The drug is designed to prevent its crossing the blood-brain barrier and affecting the central nervous system, researchers said. Medscape (free registration) (05/18)


Dopamine may be factor in chronic pain, study says

American Pain Society SmartBrief | May 13, 2015

Study: Pain risk tied to life events but not biological changes

American Pain Society SmartBrief | May 06, 2015

Study of ancient skeletons sheds light on lower-back pain

American Pain Society SmartBrief | Apr 29, 2015

Study supports neurological basis for fibromyalgia

American Pain Society SmartBrief | May 20, 2015

Poor sleep quality may affect pain sensitivity, study says

American Pain Society SmartBrief | May 13, 2015

Sleep problems may affect pain sensitivity, study says

American Pain Society SmartBrief | May 06, 2015

Study: Drug abuse prediction model may improve opioid prescribing

American Pain Society SmartBrief | May 20, 2015

Tension headaches tied to muscle weakness, imbalances

American Pain Society SmartBrief | May 06, 2015

Study: MRI modic changes linked to low-back pain

American Pain Society SmartBrief | May 06, 2015


Find American Pain Society SmartBrief Issues by Date:





Sign up for American Pain Society SmartBrief



Designed specifically for the pain professional, the APS SmartBrief is a FREE, weekly e-mail newsletter. By providing the latest need-to-know industry news and information, APS SmartBrief saves you time and keeps you smart. Learn more